Granules India's US Packaging Facility Receives FDA Inspection Report with No Action Indicated

Granules India's US subsidiary, Granules Consumer Health, received a second Establishment Inspection Report (EIR) with a No Action Indicated (NAI) status from the US FDA for its packaging facility in Manassas, Virginia, following inspections in March 2023 and December 2025. The facility processes controlled substances and OTC products across three packaging lines. Granules India reported a 27.73% rise in consolidated net profit to Rs 150.21 crore in Q3 FY26, supported by a 22% revenue increase.